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Case Presentation
A 63-year old former carpenter was referred
in 1988 to the Center for Occupational and
Environmental Medicine (COEM), at the
Massachusetts Respiratory Hospital,
Braintree, Massachusetts, for evaluation of
possible asbestos-related lung disease. In
1948 he had begun to work in a shipyard
and was involved in the construction,
repair, and demolition ofvessels. He often
worked below deck in enclosed environ-
ments, where he was exposed to visible
clouds of asbestos dust. Like other workers
in the postwar shipbuilding industry, he
was not warned that asbestos exposure
could be hazardous and he did not wear a
respiratory protective device. In 1963 he
changed to a desk job and had no further
known asbestos exposures. By 1988, the
news that his former co-workers at the ship-
yard were being diagnosed with asbestos-
related lung disease prompted him to seek
medical screening.
He first consulted a primary care physi-
cian. At the time, he was physically very
active and denied dyspnea, cough, sputum
production, chest pain, palpitations, or
fatigue. He had never smoked cigarettes,
although he had occasionally smoked cig-
ars and pipes in the past. However, his sec-
ond wife smoked two to three packs ofcig-
arettes per day at home, and his co-workers
at his various workplaces often smoked cig-
arettes on the job. He was diagnosed with
mild diabetes mellitus, which was well con-
trolled with 2.5 mg glipizide/day.
A posteroanterior chest radiograph
revealed bilateral pleural plaques and mild
diffuse interstitial fibrosis (Fig. 1A). At this
point, the patient was referred to this cen-
ter. Studies of his ventilatory function
included forced vital capacity (FVC),
forced expiratory volume in 1 sec (FEV1),
total lung capacity (TLC), residual volume
(RV), calculated FEV1/FVC, and a single-
breath diffusing capacity for carbon
monoxide (DLCO). These tests showed a
moderate restrictive defect with a normal
diffusing capacity (Table 1). On the basis of
his occupational history, chest X-ray find-
ings, and pulmonary function studies, the
patient received a diagnosis of asbestos-
related pleural plaques and asbestosis.
The patient returned for follow-up at
the center every 1-2 years. From 1991 to
1995, the 71-year-old man reported only
mild dyspnea on exertion. During a follow-
up visit in 1996, however, he complained of
a 4-5 month history ofshortness ofbreath
while walking his dog and mowing his
lawn. On physical examination, he had
bibasilar dry "Velcro" rales, but no clubbing
or cyanosis and no remarkable findings on
cardiovascular examination.
A review of serial chest X rays (Fig.
lA-1C) from 1988, 1992, and 1996 sug-
gested aworsening ofhis interstitial lung dis-
ease. Comparison of high-resolution com-
puted tomography (HRCT) scans obtained
in 1991 and 1996 provided firmer evidence
that the bilateral interstitial process had pro-
gressed from moderate to severe and also
yielded additional evidence of pleural
plaques (Fig. 2). Moreover, serial pulmonary
function studies from 1988, 1992, and 1996
revealed an increase in the patient's restric-
tive defect, with more rapid declines in his
lung volumes between 1992 and 1996 than
between 1988 and 1992. His FVC of 2.34
liters (61% ofpredicted) in 1988 dropped to
1.89 liters (52% ofpredicted) in 1992, and
then to 1.25 liters (35% of predicted) in
1996. His TLC of3.61 liters (60% predict-
ed) in 1988 dropped to 3.22 liters (55% of
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Figure 1. Chest X rays
from (A) 1988, (B) 1992,
and (C) 1996.
Table 1. Pulmonary function tests
FEV1/FVC Single-breath
Test Date FEVy (I) FVC (I) (% Pred) TLC DLCO (% Pred)
Prebronchodilator 1988 1.92 (61)a 2.34(61) 101 3.61 (60) 85
1992 1.59(54) 1.89(52) 105 3.22 (55) 85
1996 1.03 (37) 1.25 (35) 104 2.33 (40) 59
Postbronchodilator
1988 2.04 (65) 2.48 (65) 101
1992 1.70 (58) 1.97 (55) 107
1996 1.16 (42) 1.30 (37) 113
Abbreviations: FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffus-
ing capacity for carbon monoxide; % Pred, percent of predicted.
8Values shown in parentheses are '4 Pred.
predicted) in 1992 and then to 2.33 liters
(400%.) of predicted) in 1996. Of niote, his
pulmonary funlctioin tests alsc) srtggested a
mild bronchodilator response (Table 1).
Other studies revealed that the patient's
single-breath diffusing capacity was normal
at 85% ofpredicted from 1988 to 1992, btit
dropped sharply to 59% of predicted in
1995 ([able 1 ). His arterial blood gas oni
room gas in 1996 showed a pH of 7.40, a
pCo, (partial pressure) of 46 mmHg, a
pO), of67 mmHg, aind an oxygen satriration
of 93%. However, when exercise oximetry
was coniducted as a study of his funictionalj
capacity, his oxygen satiiration dropped to
88% after he wailked 1,100 feet in 6 mrir. It
was cvident that the patient's interstitial
lung disease was progressing rapidly and that
he was becoming hypoxemic.
A workup was initiated for conditions
other than asbestosis that could be contribut-
ing to a more acute course. No clinical evi-
denlce was found to suggest hypersensitivirY
pneumionitis or systemic diseases associated
with ptilmonary fibrosis, such as rheumatoid
arthritis, collagen vascular disease, or sar-
coidosis. Lung biopsy, either open or trans-
bronchial, was not undertaken because ofthe
patient's low pulmonary reserve and limited
treatment options. Given the possibility,
however small, that he may have had a
stcroidl-responsive condition, an empiric trial
of60 tmg ofpredniisonec per day was initiated
Despite this therapy, his pulmonary stcati.
continnued to deteriorate, and he dicd at 2
years ofage ofpulmonanr failure. [he fantile
did not elect to1have an autopsy perf.ormn-cd.
Discussion
Asbestos is a generic comm-iercial termn for a
group of mineral silicates that crystallize -js
fibers and are resistanti to temiperatures ais
high as 8O00W and to corrosive chiemicals.
Although asbestos has beeni mined and
used for several centiuriLes, it was flrst widely.
used in the United Stares durinig the 1940s
in the manufacturC of asbestos cemncti
products, floor tile, inisulation aind fir-
proofing, textiles, asbestos paper, aind fri-
tion materials. In this country, the higheist
level occupational exposures to asbestos
have occurred in the repair and demolition
of buildings aind ships, particularly affect-
ing pipe fitters, boilermakers, atiid other
workers in the building trades (1)
the miassive shipbtilding elffl-ort o)f Woldt1
War 11 placed the largest segncint ofworker-s
in the United States ait risk for- de({velop)ing
asbestos-rela,ited disease (Fig. ). Skip coti
strtiction enitailed unustallyinltensie uIse ofi
insulating materials. -he ri.isk ws iagnifiecdi
by the relaxation of wrkplace s,iftyt eflobrvts
in the wartinmc ecollolily (2). Ships arc
uniusually vulnerable to fire becattse of thlei
isolation wihcen at sea and thelfilritmtv coo11-
fined spaces; shipbtiilding promotes itlldirectl
asbestos expostires l)ecause all work takes
place withini cnclosed, poorly venitilated, and
uninonitored environirmienits.
Asbestos fibers cati he divided into twO
categories: serpentine and amiiiphlihbole-.
Chrysolite, a serpentine fiber, cottOts fbr.
90% of globally pIodluCe asl)es
Amphibole fibers are of less industrial
importance aind inclIuide ctrocidolite.
atnosite, anid aithopihlyllite. StaIrrting in thei
1970s, synlthetic mieral fibers, such as
fiberglass otr slag wotol l)egan to replace
asbestos. flo'vser asbestos 'Is still tLseC in
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the manufacture of brake linings and
remains in place as pipe and boiler insula-
tion in thousands ofworkplaces and homes
in the United States. Despite knowledge of
effective means for prevention ofexposures
and institution ofstringent standards man-
dating worker training, exposure monitor-
ing, personal protection, and medical sur-
veillance, asbestos exposures are probably
continuing among untrained workers in
the United States and throughout the
developingworld (3).
Exposure to asbestos may not be limited
to persons who directly handle the material.
Indirect occupational exposures may occur
when employees work near an area ofheavy
exposure or alongside heavily exposed work-
ers, e.g., painters or electricians who work
near insulation workers in a shipyard.
Indirect paraoccupational exposures mayalso
take place in households and neighborhoods
when workers carry asbestos dust on their
clothes, shoes, hair, toolboxes, and lunch
boxes and in their automobiles. During the
1940s and 1950s in the United States, wives
of asbestos workers sustained household
exposures because they regularly shook out
orwashed theirhusbands' workclothes (4).
Asbestosis
The four pulmonary conditions caused by
asbestos include asbestosis; cancer of the
lung parenchyma; mesotheliomas of the
pleura, pericardium, and peritoneum; and
benign changes of the pleura. The term
asbestosis is usually reserved for diffuse
interstitial fibrosis of the lung, which is a
direct reaction to asbestos exposure.
Asbestosis is the prototype ofdiseases caused
by inhalation ofmineral fibers and is a form
of pneumoconiosis, disease caused by the
excessive accumulation of dusts in the lung
parenchyma (5).
Asbestosis is considered to be a slowly
progressive disorder, but the extent to which
clinical and exposure parameters among
individuals with asbestosis can quantitatively
predict death from this disease remains to be
darified. The development ofdiffiuse inter-
stitial fibrosis may relate to the intensity and
duration of exposure; at least 10 years of
exposure usually occur before the manifesta-
tion ofdisease. As in our patient, the subse-
quent chronic inflammation, collagen depo-
sition, and scarring seem to progress despite
cessation ofexposure (6).
The etiology of asbestosis unclear, but
there are two major hypotheses. The oxygen
radical hypothesis states that asbestos-
induced production of reactive oxygen
species (ROS) may be an important media-
tor of asbestosis development. When
asbestos fibers are inhaled and deposited in
the lung parenchyma, alveolar macophages
accumulate at the site. During phagocytosis,
macrophages secrete hydrogen peroxide.
Asbestos fibers may act as intracellular or
extracellular substrates for the generation of
ROS from hydrogen peroxide molecules,
and ironwithin the fibers or redoxactive iron
Figure 2. High-resolution computedtomography(HCRT) scans obtained in (A) 1991 and(B) 1996.
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Figure 3. World War 11 shipyard in San Francisco, California.
associated with or mobilized from the fibers
may serve as catalytic agents. ROS in turn
may cause DNA damage and cellular toxicity
(4. The growth factor hypothesis offers an
alternative, though not mutually exclusive,
explanation. According to this hypothesis,
induced cytokines, growth factors, and other
proteins act in concert with inflammatory
cells to mediate fibrinogenesis (8). It seems
that the full expression of asbestosis is com-
plex, involving the activation ofinflammato-
ry cells, the generation ofROS, and the acti-
vation ofa multitude ofproteins that medi-
ate lung tissue inflammation, injury, and
repair at the DNAand cellular levels.
In a necropsy study oftextile workers in
South Carolina (9), lifetime cumulative
exposure and total lung fiber burden were
strongly correlated with severity of asbesto-
sis. In addition, both asbestosis and lung
cancer were strongly correlated with expo-
sure to the long fibers ofchrysotile.
It is possible that some workers have a
genetically enhanced susceptibility to
asbestosis. One approach to the investiga-
tion of this area of concern is to look for
genetic polymorphisms in the genes encod-
ing for enzymes that repair damage caused
by ROS. To date, researchers have focused
mainly on metabolic enzymes, such as glu-
tathione S-transferase (GST) m and q
enzymes, for which homozygous deletions
resulting in no enzyme production have
been reported to be associated with
increased radiographic evidence ofasbestosis
(10,11). Hirvonen et al. (12) found that the
NAT2 slow acetylator genotype was more
strongly associated with asbestosis than the
GSTI deletion. However, many genes and
gene products are probably involved in the
dynamic processes of damage and repair
through complex mechanisms related to
environmental exposure, genetic susceptibil-
ity, and constitutional factors.
Asbestos-related malignancies may also
be associated with asbestosis. Many epi-
demiologic studies have provided evidence
of an elevated incidence of lung cancer
among workers with asbestosis. For exam-
ple, asbestosis patients in a recent study in
Finland had higher rates of bronchogenic
lung cancer [standardized incidence rate
(SIR) = 10] and mesothelioma (SIR = 65)
than the general population (13). The devel-
opment oflung cancer among the asbestosis
patients was associated with more rapid
radiographic progression of small opacity
profusion (37 for rapid progressors vs. 4.3
for nonprogressors) (14). However, there are
conflicting data on whether asbestosis is a
prerequisite for lung cancer in the setting of
asbestos exposure (15).
The initial evaluation of a worker with
suspected asbestos-related pulmonary dis-
ease should include a clinical history, an
exposure history, a smoking history, a phys-
ical examination, and anteroposterior chest
X rays. The clinical history should focus on
cardiopulmonary symptoms. An explo-
ration of cardiac symptoms and functional
capacity is important because cardiovascular
disease must be excluded in the target age
group. The worker with asbestosis may
complain ofchronic dry cough and dyspnea
on exertion, but the degree of symptoms
may not correlate well with the extent of
disease. Occupational and exposure histories
are important in estimation of the duration
and extent of asbestos exposure. Smoking
history, including passive smoking, is also
pertinent to the overall assessment of pul-
monary function.
Typically, auscultation of the lungs
reveals end-inspiratory basilar "Velcro" rales,
the classic finding of pulmonary fibrosis.
The examiner should be attentive to find-
ings related to hypoxemia, such as digital
clubbing, cyanosis, and tachypnea. The
physical examination should be comprehen-
sive because pulmonary fibrosis is nonspecif-
ic; many systemic diseases such as rheuma-
toid arthritis and scleroderma may produce
lung findings similar to those ofasbestosis.
In cases with a positive history and phys-
ical findings, chest radiography should be
used for indirect visualization of the lungs.
Asbestosis is characterized radiographically
by small opacities, most prominent at the
lung bases. The size and number (profusion)
of these opacities increases with the severity
ofdisease. In severe disease, obscuring ofthe
diaphragmatic and cardiac borders leads to
the "shaggy" heart sign. In 1980, the
International Labor Organization (ILO)
published a classification scheme for the
radiographic assessment of pneumoconiosis
based on the size and profusion ofopacities
(16). There are limitations to the sensitivity
and specificity ofchest radiography and ILO
profusion scoring. Chest radiography is
unreliable in diagnosing and following the
progression of interstitial lung disease. The
chest radiograph may be normal in the set-
ting ofmoderate interstitial fibrosis, whereas
cigarette smokers tend to have an excess of
small, irregular opacities and a relatively
high profusion score, even without histolog-
icallyverified interstitial fibrosis (17,18).
Pulmonary function testing is used to
augment the clinical database. The earliest
changes include diminished vital capacity
(VC), reduced DLCO, and an increase in
static lung recoil pressures. Subsequent
changes include an increase in resting and
exercise minute ventilation, arterial desatu-
ration with exercise and later at rest, dimin-
ishing TLC, and increased dead space (dead
space volume/tidal volume). Large-airway
obstruction may be present; this phenome-
non is more likely in smokers who have
centrilobular emphysema, but is also seen to
a lesser extent in nonsmoking asbestos-
exposed workers. Small-airway disease may
be evident, but is nonspecific in that it may
reflect peripheral bronchiolar inflammation
and fibrotic narrowing, airway obstruction
caused by smoking, or increased lung recoil
caused by interstitial fibrosis (17,19).
Obstructive changes have been observed in
asbestosis cases with lower small-opacity
profusion scores and prior to more
advanced fibrotic stages, in which increased
recoil secondary to fibrosis has overcome
the effect of decreased airflow (20). Agusti
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et al. (21) studied patterns ofgas exchange
in response to exercise in asbestosis and
idiopathic pulmonary fibrosis; they found
more obstruction on exercise. These differ-
ences may relate to the underlying mor-
phology of each process: asbestosis may
include more airway disease and less pul-
monary vascular involvement than other
forms ofpulmonary fibrosis.
Asbestos exposure as a distinct cause of
pulmonary obstruction is controversial
because it is difficult to separate smoking as
a confounder (19,22). In our patient, per-
haps exposures to both asbestos and envi-
ronmental tobacco smoke manifested in
obstructive changes. Furthermore, it has
been suggested that smoking and asbestos
act synergistically to promote both restric-
tive and obstructive pulmonary disease. For
example, Neri et al. (22) studied shipyard
workers who smoked and were exposed to
asbestos: current smokers or ex-smokers
with high profusion scores had more
obstructive changes, as manifested by lower
FEVI/FVC ratios, than current smokers or
ex-smokers with low profusion scores and a
shorter duration ofsmoking. Damage from
smoking may decrease the ability to clear
inhaled asbestos fibers and increase the per-
meability ofthe airwaywalls, allowing easier
penetration byasbestos fibers (23).
HRCT scans are considered to be more
sensitive than plain films for detecting inter-
stitial fibrosis. There is growing evidence that
through increased contrast resolution and
axial image display, HRCT can detect both
interstitial and pleural disease in advance of
clinical symptoms or positive conventional
clinical or radiographic studies (22,24). In
addition, HRCT findings have a greater cor-
relation with the duration of asbestos expo-
sure (22), the presence ofmoderate to severe
dyspnea, a high ILO chest X-ray classifica-
tion, alowFVC, and ahigh concentration of
macrophages and eosinophils in bron-
choalveolar lavage fluid (25). In combined
asbestos and cigarette smoke exposure,
HRCT may play a role in distinguishing
emphysematous lung destruction from
peripheral interstitial changes of asbestosis
(24). However, expense, time, and the lack
of established standards for technique and
image interpretation make the use ofHRCT
inappropriate for initial screening (21,26). At
present, HRCT is being used in the United
States to supplement chest radiography in
selected cases.
Asbestosis can also be diagnosed on
pathologic grounds. Histologic diagnosis
requires the detection of diffuse interstitial
fibrosis in the usual pattern and the detection
of at least one asbestos body within tissue
sections (27). An asbestos body (Fig. 4) is an
asbestos fiber that penetrates lung tissue and
becomes coated with iron and calcium.
Ingestion of these fibers by macrophages
induces a fibrogenic response through release
of growth factors that promote collagen
deposition by fibroblasts. In pathologic lung
sections, asbestos bodies are best visualized
with an iron stain and are also known as fer-
ruginous bodies.
Although there have been a number of
studies on asbestosis-associated mortality,
our understanding ofthe risk ofdeath asso-
ciated with asbestosis remains incomplete.
Asbestosis-related mortality has been most
closely associated with time since first expo-
sure, intensity of first exposure, and con-
comitant smoking. Alimiting factor in mor-
tality studies, however, is that death due to
asbestosis may be attributed to other causes
on death certificates (28).
DistinguishingAsbestosis from
Interstitial Lung Disease ofOther
Etiologies
It may be difficult to differentiate asbestosis
from pulmonary injury resulting from
inhalation of other toxic dusts and from
other forms of diffuse interstitial pul-
monary fibrosis ofboth the idiopathic and
known types. Asbestos-exposed workers are
often exposed to many other dusts as well.
In shipyards, workers may be exposed to
silica, talc, and welding fumes in addition
to asbestos. Silicosis can be readily distin-
guished from asbestosis on a radiographic
basis because it typically produces a cir-
cumscribed nodular pattern of fibrosis in
the upper lobes rather than the irregular
linear type offibrosis that predominates at
the lung bases. Bronchiolitis obliterans
organizing pneumonia can be differentiat-
ed from asbestosis on the basis ofthe histo-
logic finding of plugs of edematous con-
nective tissue filling the alveolar spaces and
alveolar ducts (17). Most other diseases
that cause diffuse pulmonary fibrosis are
not easy to differentiate from asbestosis.
Nevertheless, the distinction is important
in terms oftreatment options. Some inter-
stitial diseases respond to steroids, such as
bronchiolitis obliterans organizing pneu-
monia, desquamative interstitial pneumo-
nia, and sarcoidosis.
"Interstitial lung disease" describes the
dinical outcome of more than 100 diseases
ofboth known and unknown causes (29).
Theknown causes indudethefollowing:
* Asbestos
* Silica
* Organic dusts
* Fumes, gases
* Drugs (antibiotics and chemotherapy
drugs)
* Radiation
*Aspiration pneumonia
Figure 4. Asbestos body. Reproducedwith permis-
sion from Edward C. Klatt, Department of
Pathology, University of Utah [available:
http://www-medlib.med.utah.edu/WebPath/
LUNGHTML/LUNG082.htmlJ.
* Residual ofadult respiratorydistress
syndrome.
The unknown causes indude:
* Idiopathic pulmonaryfibrosis
* Collagen vasculardiseases
* Systemic lupus erythematosus, rheumatoid
arthritis, ankylosing spondylitis, systemic
sderosis, Sjogren's syndrome, polymyosi-
tis-dermatomyositis
* Pulmonaryhemorrhage syndromes
* Goodpasture's syndrome, idiopathic pul-
monaryhemosiderosis
* Lymphocyte infiltration disorders (lym-
phocytic interstitial pneumonitis associat-
edwith collagenvascular diseases
* Eosinophiicpneumonias
* Lymphangioleiomyomatosis
* Amyloidosis
* Inherited diseases
* Tuberous sclerosis, neurofibromatosis,
Niemann-Pick disease, Gaucher's disease,
Hermansky-Pudlak syndrome
* Gastrointestinal or liver diseases (Crohn's
disease, primary biliary cirrhosis, chronic
active hepatitis, ulcerative colitis)
* Graft versus host disease (bone marrow
transplantation).
This group of diseases has many com-
mon dinical features, including similarities
in symptoms, appearance of chest radi-
ographs, alterations in pulmonary physiolo-
gy, and histologic features. The first response
to an initiating event is inflammation in the
air spaces and alveolarwalls, which causes an
acute phase of intraluminal and mural alve-
olitis. If the exposure is chronic, inflamma-
tion may spread to adjacent interstitial and
vasculature, producing scarring and distor-
tion oflung tissue along with derangement
of gas exchange and ventilatory function.
With time, the common end point is diffuse
pulmonary fibrosis with resting ventilatory
impairment, which will obscure the identity
oftheinitiatingevent.
The chest radiograph may reveal diffuse
reticulonodular markings, particularly at the
lung bases. Other subsequently developing
radiographic patterns may correlate roughly
Environmental Health Perspectives * Volume 107, Number 4, April 1999 325Grand Rounds in Environmental Medicine * Moy et al.
with the duration of the disease. An early,
hazy, "ground-glass" appearance of the
lower-lung fields coincides with the stage of
acute alveolitis. Secondarily, curvilinear
shadows predominate and maycoalesce into
nodular infiltrates. Finally, linear opacities
are viable in all lung fields in end-stage dis-
ease. Another end-stage characteristic is
"honeycombing" due to contraction of the
lung fields in concert with cystic and
bronchiectatic changes. The absence ofradi-
ographic changes does not rule out intersti-
tial lung disease, however. Biopsy-proven
forms of diffuse interstitial lung disease
occur occasionally (-14% of cases) in
patients with normal radiographs despite
significant exercise intolerance, abnormal
pulmonaryfunction tests, andrales (29).
Many investigators think that asbestos
bodies are the key feature that distinguish
asbestosis from other interstitial lung disease.
Asbestos bodies in paraffin sections constitute
an exquisitely specific marker ofsignificant
exposure to asbestos. However, asbestos bod-
ies lacksensitivity as a marker ofexposure. In
addition, chrysotile fibers accumulate in the
lung to a greater extent than amphibole
fibers. Therefore, the lack ofasbestos bodies
may not be informative in the evaluation of
amphibole-exposed workers (27).
For medicolegal purposes, tissue diagno-
sis is not necessary for adiagnosis ofasbesto-
sis. In 1986, the American Thoracic Society
stated that this diagnosis ofasbestosis should
be based on a careful consideration ofall rel-
evant clinical findings, induding a reliable
history ofexposure and an appropriate inter-
val between exposure and detection.
Furthermore, the society considered the fol-
lowing clinical criteria to beofvalue: 1) chest
roentgenographic evidence of type "s," "t,"
"u," small irregular opacifications ofa profu-
sion of 1/1 or greater (1/0 is generally con-
sidered sufficient, but the committee chose
1/1 because the ILO standard did not con-
tain a 1/0 reference); 2) a restrictive pattern
oflung impairment with an FVC below the
lowerlimit ofnormal; 3) a DLCO below the
lower limit ofnormal; and 4) bilateral late or
pan-inspiratory crackles not cleared by
cough, at the posteriorlungbases (30).
In the case we describe here, we proposed
an initial diagnosis ofasbestosis in 1988 based
on occupational history and the presence of
pleural plaques, pleural fibrosis, and mild
interstitial fibrosis. The progression ofclinical
interstitial fibrosis that this patient experi-
enced after 1995 seemed to be more rapid
than usual for asbestosis, however, suggesting
that the patient's disease process represented
either avariant ofasbestosis or aprocess unre-
lated to asbestos exposure. As our case illus-
trates, obtaining aprecisediagnosis can bedif-
ficult. Open lung biopsy is the best method
for obtaining adequate lung tissue for histo-
logic examination, microbial cultures, and
immunofluorescence and electron microscope
studies; atransbronchial lungbiopsy is usually
not sufficient. However, thispatient's low res-
piratoryreserve, advancedstageofdisease, and
limited treatment options dissuaded us from
performing eitheropen ortransbronchial lung
biopsy. Since no theraputic options are cur-
rently available for reversing or stabilizing
asbestosis and because we thought that this
patient might have had a concomitant condi-
tion that was steroid responsive, we opted for
empiric treatmentwithcorticosteroids.
In the United States, with decreasing
exposure to asbestos and promotion ofper-
sonal protection equipment, the incidence of
classical asbestosis will decrease in the next
few decades. When physicians encounter a
patientwithpulmonaryfibrosis and ahistory
ofasbestos exposure, thepossibilityofasepa-
rate or superimposed process leading to pul-
monary fibrosis should begiven more serious
consideration.
Asbestos:The Public Health Oudook
Today, most patients with asbestos-associated
diseases who present to health care facilities
were first exposed to asbestos before 1970.
Since 1972, the Occupational Safety and
Health Administration has passed asbestos
standards for general industry (29 CFR §
1910.1001), for shipbuilding (29 CFR §
1915.1001), and for construction (29 CFR §
1926.1101). The current 8-hr time-weighted
average permissible exposure limit for
asbestos is 0.2 fibers/cm3 of air, and the
short-term excursion limit is 1 fiber/cm3 of
air over a sampling period of30 min (31).
The EPA has also regulated asbestos under
the Clean Air Act; the Clean Water Act; the
Comprehensive Environmental Response,
Compensation, and Liability Act; the Food,
Drug, and Cosmetic Act; the Resource
Conservation and Recovery Act; the Safe
Drinking Water Act; the Superfund
Amendments and Reauthorization Act; and
theToxicSubstances ControlAct (32.
These regulations have resulted in the
reduction ofboth asbestos use and asbestos
exposures in the United States, and
asbestos-related disease in the United States
is nowlikely to be a result ofpast exposures.
However, physicians who treat immigrant
populations or work in international health
settings should be aware that asbestos expo-
sures are on the rise in developing coun-
tries. Ironically, hazardous industries, espe-
cially those involving substances banned in
the United States, are being exported to
developing countries. The production of
asbestos has been rising in countries such as
Brazil, China, and the former Soviet Union.
In addition, the importation and use of
asbestos in manufacturing has shifted from
North America and western Europe to
industrializing countries such as Brazil,
China, India, Japan, Pakistan, and South
Korea (33-35). The regulation of asbestos
use differs from country to country, and it
is likely that manyworkers are being placed
at high risk of asbestos-related diseases
because ofa lack ofstringent regulations, a
lack of knowledge about health risks, and
potentiating risk factors such as malnutri-
tion and the high prevalence of infectious
diseases (36,327).
Exposures of the general population to
asbestos fibers in air, drinking water, bever-
ages, and foods should also be of concern.
Like occupational exposures, environmental
exposures to asbestos are accentuated in
developing countries. There may be signifi-
cantasbestos dust in oldbuildings, particular-
ly buildings that are undergoing reconstruc-
tion. Factories that process asbestos or use
asbestos in manufacturing may be releasing
fibers into the airbecause ofinadequate engi-
neering controls (38). The key to preventing
asbestos-related lung disease is to control
exposures to asbestos in both occupational
and environmental settings and in developing
as well as developed countries. Physicians
maycontribute to this effort through accurate
diagnosis anddisease reporting.
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